TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Pain Evaluated by a Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of drug-induced liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Maximum Tolerated Dose of BPU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to 1st analgesic request with OPS ≥4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in nasal provocation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ground reaction forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum CICP (c-terminal propeptide of type 1 collagen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum CTX (c-terminal telopeptide of type 1 collagen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Digestive decolonization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: long term safety and effectiveness of Novilase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with abnormal CogState battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cerebrospinal fluid levels of secondary lymphoid organs chemokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fat-free Mass (FFM) For-age Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cecal Intubation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage Reduction in Intracranial Pressure (ICP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Absolute Intracranial Pressure (ICP) Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration To Achieve ICP Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tinnitus handicap inventory change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: tinnitus suffer
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total Brain Atrophy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Verbal Memory Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vessel stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety data evaluation
Endpoint domain: Adverse events/effects
Primary endpoint: Expanded Disability Status Scale Score (EDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed 25-foot Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nine-hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients completing the prescribed therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency and severity of acute adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of chronic adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Cognitive function at 7 days
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline Swallowing function at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patency of hemodialysis circuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pentacam analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in K-BILD health status score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's Anxiety Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Validation of cutaneous insulin tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of and Severity of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Immunogenicity of AVR-RD-01
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in the Average Number of Gb3 Inclusions (ie, Myelinosomes) Per Kidney Peritubular Capillary (PTC) Per Subject
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycated haemoglobin (HbA1c) percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of MS Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Pain-related Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Youth Outcomes Questionnaire 30-item (YOQ30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Brief Aggression Questionnaire (BAQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EUS-E accuracy qualitative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EUS-E accuracy quantitative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Achieving a Response in Mucosal or Cutaneous Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute change in PTX3 plasma values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Titanium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS anticipatory anxiety measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in ACQ-6 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survival of osteosarcoma
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline for vital sign and ECG parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum antibodies levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly spontaneous bowel movement (SBM) number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory Neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Respiratory severity score (RSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tracheal aspirate cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Breast appearance and cosmetic effect score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Upper GI symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tooth pain modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Who Complete Entire Treatment Course
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Systemic Exposure to Paclitaxel and Carboplatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss on post-operative day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ocular hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percent Change in Eosinophil Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Optimal dose determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitoring for delayed adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in global physical activity time per week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in endoscopic Nasal polyp score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) 0-48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted risk of overdose in patients with opioid exposure (prescribing/dispensing)
Endpoint domain: Mortality/survival
Primary endpoint: Adjusted risk of overdose in patients with opioid-inclusive substance use disorder diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Adjusted risk of emergency department and inpatient utilization in patients with opioid exposure (prescribing/dispensing)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Revised Memory and Behavior Problems Checklist (RMBPC)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of recurrence of FSGS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of recurrence of proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Time Experiencing Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of JAK inhibitors in RA management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of JAK inhibitors
Endpoint domain: Adverse events/effects
Primary endpoint: Methacetin Breath Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MR Elastography Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in McGill Pain Questionnaire (MPQ)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change from Baseline in Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Symptoms of benign prostate hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exposure of darunavir (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity measured by antibody titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Resting E/E'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-exercise E/E'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response Rate (RR) at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Number of Post-index Asthma-related Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Sustained Virologic Response (SVR) at 12 Weeks After Discontinuation of Therapy (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum levels of adipose tissue hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in serum levels of lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in serum levels of osteomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of MRD (marginal reflex distance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Flow-mediated Dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Objective Child Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy of the nurse in the detection of child abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the individual performance on screening child abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Occurrences of Painful Sickle Cell Crises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain management outcomes
Primary endpoint: B-type lines on thoracic point-of-care ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter of inferior vena cava on thoracic point-of-care ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained histological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time spent in the target glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of cigarette puffs obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival without locoregional lymph node recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Symptoms associated with vagus nerve injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor Site Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Muscle Flap Viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevention of Antibiotic-Associated Diarrhea (AAD)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in percent cholesterol excretion per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in removal rate of esterified cholesterol from plasma per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Success Rate 1 (SR1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change From Baseline in Total Lesion Counts at Week 12 Using Last Observation Carried Forward (LOCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change From Baseline in Total Lesion Counts at Week 12 Using Last Observation Carried Forward (LOCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROC AUC for Model 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women starting active phase of labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: IOP lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Regressive Response Rate (ORRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the training protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of supervised high-intensity exercise training
Endpoint domain: Adverse events/effects
Primary endpoint: number of interventions done according to the active decision support system
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: duration of use of active decision support system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pre-Sleep Arousal Scale (PSAS) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep Diaries (Total Wake Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Total Sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of holes in surgeons gloves
Endpoint domain: Adverse events/effects
Primary endpoint: TH-17 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Hand Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in grip and lateral pinch strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breathlessness intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isoform distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline Quality of Life at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Patients With 17-OHP Levels Equal or Below 1,200 ng/dL at 0700
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: steady-state plasma concentration of theophylline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fasting triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: APA bias scores at Time 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APA bias scores at Time 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Habitual physical and sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment of eligible study participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attendance at group sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Immune response to PCV13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of curcumin
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Hepatitis B (HB)-Specific CD4+ T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of the treatment plan
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Treatment Emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, nature, and intensity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of nasal blockage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YGTSS-TTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in macular pigment distribution and concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression severity as measured by the HRSD17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diphtheria and Tetanus Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pertussis and Filamentous Haemagglutinin Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Polio Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hepatitis B and Haemophilus Influenzae Type B Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in the St. George's Respiratory Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-perceived wheat and/or gluten-sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported physical activity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily frequency of hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease related Treatment Failure (DrTF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success without failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two Year Prostatic Specific Antigen (PSA) Failure Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LV EDV post surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: oocyte number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: FEV1 spirometry measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SaO2 (Arterial Oxygen Saturation) - pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Heart rate (HR) - pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nightmare Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in self-reported sexual risk taking
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Amount of protrusion (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone Mineral Density - Lumbar Spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of peri-procedural myonecrosis
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Asthma Control Questionnaire (ACQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Achieving eRVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes